Severe combined immunodeficient mouse models of human leukemia

Blood

Volumn 88, Issue 4, 1996, Pages 1135-1146

  Uckun, Fatih M ^a,b  

^a Children's Cancer Group   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIBODY CONJUGATE; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CARMUSTINE; DOXORUBICIN; ETOPOSIDE; GYRASE INHIBITOR; METHYLPREDNISOLONE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VINCRISTINE;

ANIMAL CELL; ANIMAL MODEL; CELL GROWTH; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0029839239     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.4.1135.bloodjournal8841135     Document Type: Review

References (47)

1. Bosma MJ, Carroll AM: The SCID mouse mutant: Definition, characterization, and potential uses. Annu Rev Immunol 9:323, 1991
2. Dick JE: Immune-deficient mice as models of normal and leukemic human hematopoiesis. Cancer Cells 3:39, 1991
3. Uckun FM, Sather H, Reaman G, Shuster J, Land V, Trigg M, Gunther R, Chelstrom A, Bleyer A, Gaynon P, Crist W: Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia. Blood 85:873, 1995
4. Cesano A, Hoxie JA, Lange B, Nowell PC, Bishop J, Santoli D: The severe combined immunodehcient (SCID) mouse as a model for human myeloid leukemias. Oncogene 7:827, 1992
5. Uckun FM, Downing JR, Chelstrom LM, Gunther R, Ryan M, Simon J, Carroll AJ, Tuel-Ahlgren L, Crist W: Human t(4;11)(q21;q23) acute lymphoblastic luekemia in mice with severe combined immunodeficiency. Blood 84:859, 1994
6. Gunther R, Chelstrom LM, Finnegan D, Tuel-Ahlgren L, Irvin JD, Myers DE, Uckun FM: In vivo anti-leukemic efficacy of anit-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency. Leukemia 7:298, 1993
7. Uckun FM, Downing JR, Gunther R, Chelstrom LM, Finnegan D, Land VJ, Borowitz MJ, Carroll AJ, Crist CM: Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 81:3052, 1993
8. Cesano A, O'Connor R, Lange B, Finan J, Rovera G, Santoli D: Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice. Blood 77:2463, 1991
9. Dick JE, Lapidot T, Pflumio F: Transplantation of normal and leukemic human bone marrow into immune-deficient mice: Development of animal models for human hematopoiesis. Immunol Rev 124:25, 1991
10. Mueller BM, Reisfeld RA: Potential of the SCID mouse as a host for human tumors. Cancer Metastasis Rev 10:193, 1991
11. Chelstrom LM, Gunther R, Simon J, Raimondi SC, Krance R, Crist WM, Uckun FM: Childhood acute myeloid leukemia in mice with severe combined immunodeficiency. Blood 84:20, 1994
12. Lapidot T, Sirard C, Vormoor J, Minden M, Hoang T, Dick JE: AML blast cells obtained from newly diagnosed patients engraft and proliferate in SCID mice in response to cytokines. Blood 80:321, 1992
13. Sawyers CL, Gishizky ML, Quan S, Golde DW, Sitte O: Propagation of human blastic myeloid leukemias in the SCID mouse. Blood 79:2089, 1992
14. DeLord C, Clutterbuck R, Titley J, Ormerod M, Gordon-Smith T, Miller J, Powles R: Growth of primary acute leukemia in severe combined immunodeficient mice. Exp Hematol 19:991, 1991
15. Beran M, Pisa P, Kantarjian H, Porwit A, Bjorkholm M: Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice. Hematol Pathol 8:135, 1994
16. Beran M, Pisa P, O'Brien S, Kurzrock R, Siciliano M, Cork A, Andersson BS, Kohli V, Kantarjian H: Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase. Cancer Res 53:3603, 1993
17. DeLord C, Clutterbuck RD, Powles RL, Min T, Titley JC, Millar JL: Human Philadelphia chromosome-positive chronic myeloid leukemia: A potential model for antisense therapy. Exp Hematol 21:826, 1993
18. Skorski T, Nieborowska-Skorska M, Calabretta B: A model of Ph positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice. Folia Histochem Cytobiol 30:91 1992
19. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eavas A, Lansdorp PM, Eaves CJ, Dick JE: Normal and leukemic SICD-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87:1539, 1996
20. Kobayashi R, Picchio G, Kirven M, Meisenholder G, Baird S, Carson DA, Mosier DE, Kipps TJ: Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency. Leuk Res 16:1013, 1992
21. Kawata A, Han T, Dadey B, Weier HU, Okazaki M, Yokota S, Fukiage T, Xiao H, Block AM, Barcos M, Henderson E, Yoshida M, Seon BK: Establishment and characterization of the tumors of chronic lymphocytic leukemia cell line in nude and SCID mice. Leuk Res 17:883, 1993
22. Cattan AR, Douglas E: The C.B.17 SCID mouse strain as a model for human disseminated leukemia and myeloma in vivo. Leukemia Res 18:513, 1994
23. Messinger Y, Chelstrom L, Gunther R, Uckun FM: Selective homing of human leukemic B-cell precursors to specific lymphohematopoietic microenvironments in SCID mice: A role for the β1 integrin family surface adhesion molecules VLA-4 and VLA-5. Leuk Lymphoma (in press)
24. Kamel-Reid S, Letarte M, Doedens M, Greaves A, Murdoch B, Grunberger T, Lapidot T, Thorner P, Freedman MH, Phillips RA, Dick JE: Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in SCID mice. Blood 78:2973, 1991
25. Greaves MF: Differentiation linked leukemogenesis in lymphocytes. Science 234:697, 1986
26. Champlin R, Gale RP: Acute lymphoblastic leukemia: Recent advances in biology and therapy. Blood 273:2051, 1989
27. Pui CH: Childhood leukemias. N Engl J Med 332:1618, 1995
28. Copelan EA, McGuire EA: The biology and treatment of acute lymphoblastic leukemia in adults. Blood 85:1151, 1995
29. Kamel-Reid S, Letarte M, Sirare C. Doedens M, Grunberg T, Fulop G, Freedman MH, Phillips RA, Dick JE: A model of human acute lymphoblastic luekemia in immune-deficient SCID mice. Science 246:1597, 1989
30. Stranks G, Height SE, Mitchell P, Jadayel D, Yuille MAR, DeLord C, Clutterbuck RD, Treleaven JG, Powles RL, Nacheva E, Oscier DG, Karpas A, Lenoir GM, Smith SD, Millar JL, Catovsky D, Dyer MJS: Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood 86:893, 1995
31. Steele JPC, Mitchell PLR, Clutterbuck RD, Powles RL, Catovsky DL, Morilla R, Cayuela J, Sigaux F, Dyer M, Zani V, Heward J, Jaydayel D, Millar JL: T-cell acute lymphoblastic leukemia (T-ALL): Engraftment in SCID mice. Blood 86:782a, 1995 (abstr, suppl 1)
32. Manabe A, Kaneko H, Fujimoto J, Inaba T, Takeuchi M, Ohira M, Mori T, Hosoya R: Demonstration of bone involvement associated with t(17:19) acute lymphoblastic leukemia (ALL) in severe combined immunodeficiency mice. Blood 86:768a, 1995 (abstr, suppl 1)
33. Gunther R, Chelstrom LM, Tuel-Ahlgren L, Simon J, Myers DE, Uckun FM: Biotherapy for xenografted human central nervous sytem leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin. Blood 85:2537, 1995
34. Schiffer CA: Acute myeloid leukemia in adults, in Holland JF, Frei E, Bast RC, Kufe DW, Morion DL, Weichselbaum RR (eds): Cancer Medicine. Philadelphia, PA, Lea & Febiger, 1993, p 1907
35. Cesano A, Vissoneau S, Cioe L, Clark SC, Rovera G, Santoli D: Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach. J Clin Invest 94:1076, 1994
36. DeLord C, Clutterbuck R, Powles R, Morilla R, Hanby A, Titley J, Min T, Millar J: Growth of primary human acute lymphoblastic and myeloblastic leukemia in SCID mice. Leuk Lymphoma 16:157, 1994
37. Namikawa R, Ueda R, Kyoizumi S: Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. Blood 82:2526, 1993
38. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 367:645, 1994
39. Zhu Z, Ghose T, Hoskin D, Lee CL, Fernandez LA, Rowden G, Lee SH: Inhibition of human B-cell chronic lymphocytic leukemia by a monoclonal antibody in xenograft models. Int J Cancer 56:439, 1994
40. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Tuel-Ahlgren T, Chelstrom LM, Burkhardt A, Bolen J, Myers DE: Biotehrapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267:886, 1995
41. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM: Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor. Nature 379:645, 1996
42. + human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide. Blood 79:3116, 1992
43. Messinger Y, Yanishevski Y, Vassilios IA, Onur E, Chelstrom LM, Gunther R, Myers DE, Irvin JD, Evans W, Uckun FM: Treatment of human B-cell precursor leukemia in SCID mice using combinations of the investigational biotherapeutic agent, B43-PAP, with standard chemotherapeutic drugs. Clin Care Res (in press)
44. Waddick KG, Gunther R, Chelstrom LM, Chandan-Langlie M, Myers DE, Irvin JD, Tumer N, Uckun FM: In vitro and in vivo anti-leukemic activity of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against radiation resistant human pre-B acute lymphoblastic leukemia cells. Blood 86:4228, 1995
45. Cesano A, Vissoneau S, Cioe L, Clark SC, Rovera G, Santoli D: Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach. J Clin Invest 94:1076, 1994
46. Ratajczak MA, Kant JA, Luger SM, Hijiya N, Zhang J, Zon G, Gewirtz AM: In vivo treatment of human leukemia in a SCID mouse model with c-Myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 89:11823, 1992
47. Skorski T, Nieborowska-Skorska M, Wlodarski P, Calabretta B: Human leukemia treatment in SCID mice by antisense oligodeoxynucleotides targeting cooprating oncogenes. Blood 86:165a, 1995 (abstr, suppl 1)